secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nautilus Biotechnology, Inc. (NAUT)
CIK:        0001808805
Form:       8-K
Filed at:   2025-01-31T23:59:59+00:00
Accession:  0001808805-25-000002
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Two Nautilus Biotechnology directors not standing for re-election at 2025 annual meeting
--------------------------------------------------------------------------------

- Vijay Pande informed company on Jan 27, 2025, that he will not stand for re-election.
- Michael Altman informed company on Jan 28, 2025, that he will not stand for re-election.
- Both directors confirmed departure is not due to any disagreement with company operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808805/000180880525000002/0001808805-25-000002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808805/000180880525000002/naut-20250127.htm
  HTML page:      https://secwatch.observer/filing/0001808805-25-000002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer